We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App





New, Highly Accurate, POC Test Measures Level of Neutralizing Antibodies (NAb) to COVID-19, Including Variants

By LabMedica International staff writers
Posted on 22 Dec 2021

A new, highly accurate, point-of-care (POC) test can measure the level of neutralizing antibodies (NAb) to COVID-19, including variants. More...

The test, developed by scientists at the Burnet Institute (Melbourne, Australia) and the Peter Doherty Institute for Infection and Immunity (Melbourne, Australia), provides a readout from a fingerprick of blood in less than 20 minutes. The test is the first of its type globally, and could also be useful to indicate when a vaccine booster may be required. While there are many POC tests that can measure the overall level of antibody to SARS-CoV-2, and use this to estimate neutralizing antibodies, this is the only test to measure neutralizing antibody activity, which correlates with immune protection from serious disease in COVID-19.

The emergence of the Omicron variant, which early studies suggest may be up to 40-times less sensitive to patient NAb than Delta, means that some people will go from having enough NAb to be protected, to not having enough. The test provides a new option for immunity screening to support COVID-19 vaccination and control programs, particularly in time-critical and low- and middle-income settings where laboratory-based testing is difficult or impossible for many to access.

“One of the key elements of the test is that it can work with fingerprick whole blood, which is essential if it is really going to be used at point-of-care,” said study joint supervising author, Associate Professor David Anderson, Burnet Institute Deputy Director and Chief Scientific Officer of the Burnet Diagnostics Initiative.

“We envisage that this test may be part of a set of indications that will help to determine who may need a booster vaccine,” said Dr. Tom Fulford from the Doherty Institute. “This can also be adapted so that it can provide information about whether an individual has protective antibodies against particular variants of concern.”

Related Links:
Burnet Institute 
Doherty Institute 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.